DC Clinical Laboratory Technician Exam Prep Document |
2026/2027 Edition | 250 Verified Questions
DC Clinical Laboratory Technician Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive study guide contains 250 verified practice questions for the DC Clinical
Laboratory Technician Exam, covering all key domains including hematology, clinical chemistry,
microbiology, immunohematology, and laboratory safety. Each question includes a correct answer,
detailed rationale, and distractor explanations to reinforce learning. Designed for the 2026/2027 exam
cycle, this resource ensures you are fully prepared to achieve a passing score.
Abstract:
The DC Clinical Laboratory Technician (CLT) Exam is a critical certification for laboratory professionals in the
District of Columbia. This practice question bank, comprising 250 verified items, is meticulously aligned with the
2026/2027 exam blueprint. Each question tests knowledge in essential areas such as hematology (CBC
interpretation, coagulation studies), clinical chemistry (electrolytes, enzymes, therapeutic drug monitoring),
microbiology (bacterial identification, antibiotic susceptibility), immunohematology (blood typing, crossmatching),
and laboratory safety (infection control, chemical hygiene). The inclusion of thorough rationales not only explains
why the correct answer is right but also why each distractor is incorrect, promoting deep conceptual
understanding. This resource is designed to simulate the exam experience, build test-taking confidence, and
identify knowledge gaps. With updated content reflecting the latest guidelines from ASCP and CLSI, this document
is an indispensable tool for candidates aiming to achieve a high score and obtain their CLT certification in
2026-2027.
Content Area Overview:
Content Area Questions Key Topics Weight
Hematology 1-50 CBC interpretation, coagulation studies, 20%
anemia classification, WBC disorders, bone
marrow morphology
Clinical Chemistry 51-100 Electrolytes, renal function tests, liver 20%
function tests, enzymes, therapeutic drug
monitoring, acid-base balance
Microbiology 101-150 Bacterial identification, antibiotic 20%
susceptibility, virology, mycology,
parasitology, specimen collection and
handling
Immunohematology (Blood 151-200 Blood typing, antibody screening and 20%
Bank) identification, crossmatching, component
therapy, transfusion reactions
Laboratory Operations and 201-250 Quality control, laboratory mathematics, 20%
Safety infection control, chemical hygiene,
regulatory compliance, phlebotomy
Page 1
,Q1. A patient's RBCs type as A, Rh-negative, and the serum contains anti-D. The antibody screen is
negative. A crossmatch with 2 units of A-negative RBCs yields incompatible reactions at immediate
spin (IS) but negative at 37°C and AHG. Which phenomenon most likely explains these results?
A. Cold autoantibody with anti-I specificity
B. Passively acquired anti-D from Rh immune globulin
C. Antibody to a low-incidence antigen present on donor cells
D. Rouleaux formation due to elevated serum proteins
Correct Answer: D. Rouleaux formation due to elevated serum proteins
Rationale: Rouleaux causes weak, reversible agglutination that is most apparent at IS and resolves with
warm saline replacement or 37°C incubation. It is non-immune and not due to antibody. The negative
antibody screen and negative 37°C/AHG phases rule out immune-mediated incompatibility.
Why Wrong:
A - Cold autoantibodies typically react strongly at 4°C, not exclusively at IS, and would often cause
positive antibody screen.
B - Passively acquired anti-D would cause a positive antibody screen and usually react at AHG, not
confined to IS.
C - Antibodies to low-incidence antigens often react at AHG or 37°C, not exclusively at IS.
Reference: Harmening, D. (2014). Modern Blood Banking & Transfusion Practices, 6th Ed., Ch. 12.
Q2. Which laboratory result is most consistent with chronic myeloid leukemia (CML) in the chronic
phase?
A. Leukocyte alkaline phosphatase (LAP) score markedly increased with left shift
B. Cytogenetic analysis showing t(9;22) with BCR-ABL1 fusion in 90% of metaphases
C. Peripheral smear demonstrating >30% blasts with Auer rods and pseudo-Pelger-Huët cells
D. Bone marrow biopsy revealing dysplastic changes in all three lineages
Correct Answer: B. Cytogenetic analysis showing t(9;22) with BCR-ABL1 fusion in 90% of
metaphases
Rationale: The Philadelphia chromosome (t(9;22)) is diagnostic of CML and present in >90% of chronic
phase cases. LAP is decreased in CML, not increased. >30% blasts with Auer rods suggests AML, not
CML chronic phase. Dysplastic changes are characteristic of MDS.
Why Wrong:
A - LAP score is decreased in CML; increased LAP suggests a leukemoid reaction.
C - Blasts 20% in blood or marrow defines acute leukemia; Auer rods indicate AML.
D - Dysplasia in multiple lineages is diagnostic of myelodysplastic syndromes.
Reference: Bain, B. (2015). Leukaemia Diagnosis, 4th Ed., Ch. 5.
Page 2
,Q3. In a reaction catalyzed by lactate dehydrogenase (LDH), the rate of NADH oxidation is
measured spectrophotometrically at 340 nm. If the sample has a very high LDH activity, which of
the following is the most appropriate action to ensure accurate measurement?
A. Increase the incubation temperature to 37°C
B. Dilute the sample with saline and re-assay
C. Pre-incubate the sample with NAD+ to saturate coenzyme binding
D. Use a higher substrate concentration to overcome substrate inhibition
Correct Answer: B. Dilute the sample with saline and re-assay
Rationale: If LDH activity is very high, the reaction may consume all available NADH quickly, leading to
a non-linear rate and underestimated activity. Diluting the sample brings the activity into the linear range
of the assay, ensuring accurate measurement.
Why Wrong:
A - Increasing temperature increases reaction rate but does not correct for substrate depletion or
linearity.
C - Pre-incubation with NAD+ would not help; LDH uses NADH/NAD+ pair, and saturating is not
an issue.
D - Substrate inhibition is not typical for LDH; increasing substrate may cause inhibition but does
not address high sample activity.
Reference: Burtis, C.A. et al. (2012). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics,
5th Ed., Ch. 8.
Q4. A Gram-negative rod isolated from a blood culture is resistant to amikacin but susceptible to
gentamicin. Which mechanism of resistance is most likely present?
A. Efflux pump that removes amikacin but not gentamicin
B. Aminoglycoside acetyltransferase (AAC) with specificity for amikacin
C. Reduced porin expression affecting amikacin uptake more than gentamicin
D. Ribosomal methylation that alters binding of amikacin only
Correct Answer: B. Aminoglycoside acetyltransferase (AAC) with specificity for amikacin
Rationale: Aminoglycoside modifying enzymes (AMEs) such as AAC(6')-I specifically acetylate amikacin
and other aminoglycosides, while gentamicin is less affected by this enzyme. This differential resistance
pattern is classic for AAC(6')-I.
Why Wrong:
A - Efflux pumps commonly affect multiple aminoglycosides, not selectively amikacin; gentamicin
would also be affected.
C - Porin loss reduces uptake of all aminoglycosides to some extent; differential effect is unlikely.
D - Ribosomal methylation (e.g., armA) confers high-level resistance to all aminoglycosides, not just
amikacin.
Reference: CLSI M100-S25 (2015). Performance Standards for Antimicrobial Susceptibility Testing.
Page 3
, Q5. Which interpretation is correct for an ELISA assay where the patient's optical density (OD)
exceeds the cutoff established by the mean of negative controls plus 3 standard deviations?
A. The result is positive for the antibody of interest, with 99% confidence given the chosen cutoff
B. The result is indeterminate and requires confirmatory testing because the cutoff is too stringent
C. The result is considered reactive but may represent a false positive if the sample has hemolysis
D. The result indicates a high titer of antibody, as OD correlates directly with concentration
Correct Answer: A. The result is positive for the antibody of interest, with 99% confidence given the
chosen cutoff
Rationale: Using mean + 3 SD is the standard cutoff for ELISA to achieve a 99.7% specificity (assuming
normal distribution). A patient OD above this cutoff is considered positive with high probability. OD does
not directly reflect titer; titration requires serial dilutions.
Why Wrong:
B - Indeterminate zone is usually between cutoff and a lower threshold; mean+3SD is a common
positive cutoff, not too stringent.
C - Hemolysis may cause non-specific binding but does not systematically cause false positives; the
cutoff is designed to avoid such.
D - OD is not linear with antibody concentration across all ranges; titer is determined by endpoint
dilution.
Reference: Abbas, A.K. et al. (2018). Cellular and Molecular Immunology, 9th Ed., Ch. 6.
Q6. A urine specimen appears dark brown. Dipstick is negative for blood and bilirubin. Which
finding on microscopic examination would best explain the color?
A. Numerous red blood cells with dysmorphic morphology
B. Crystals of uric acid in a concentrated sample
C. Pigmented casts and presence of myoglobin casts
D. Squamous epithelial cells with hemosiderin granules
Correct Answer: C. Pigmented casts and presence of myoglobin casts
Rationale: Dark brown urine without blood or bilirubin suggests myoglobinuria or hemoglobinuria.
Myoglobinuria often results from muscle injury; myoglobin casts may be seen. Hemoglobinuria would
show free hemoglobin but the dipstick may be positive for blood. Myoglobin does not react on dipstick as
strongly, and presence of pigmented casts supports myoglobin.
Why Wrong:
A - RBCs would cause a positive dipstick for blood; the specimen would be red, not brown.
B - Uric acid crystals do not produce a dark brown color; they are yellow-brown but urine would not
be dark brown.
D - Hemosiderin granules indicate old RBC breakdown but dipstick would be positive for blood;
color would be reddish.
Reference: Strasinger, S.K. & Di Lorenzo, M.S. (2014). Urinalysis and Body Fluids, 6th Ed., Ch. 7.
Page 4
2026/2027 Edition | 250 Verified Questions
DC Clinical Laboratory Technician Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive study guide contains 250 verified practice questions for the DC Clinical
Laboratory Technician Exam, covering all key domains including hematology, clinical chemistry,
microbiology, immunohematology, and laboratory safety. Each question includes a correct answer,
detailed rationale, and distractor explanations to reinforce learning. Designed for the 2026/2027 exam
cycle, this resource ensures you are fully prepared to achieve a passing score.
Abstract:
The DC Clinical Laboratory Technician (CLT) Exam is a critical certification for laboratory professionals in the
District of Columbia. This practice question bank, comprising 250 verified items, is meticulously aligned with the
2026/2027 exam blueprint. Each question tests knowledge in essential areas such as hematology (CBC
interpretation, coagulation studies), clinical chemistry (electrolytes, enzymes, therapeutic drug monitoring),
microbiology (bacterial identification, antibiotic susceptibility), immunohematology (blood typing, crossmatching),
and laboratory safety (infection control, chemical hygiene). The inclusion of thorough rationales not only explains
why the correct answer is right but also why each distractor is incorrect, promoting deep conceptual
understanding. This resource is designed to simulate the exam experience, build test-taking confidence, and
identify knowledge gaps. With updated content reflecting the latest guidelines from ASCP and CLSI, this document
is an indispensable tool for candidates aiming to achieve a high score and obtain their CLT certification in
2026-2027.
Content Area Overview:
Content Area Questions Key Topics Weight
Hematology 1-50 CBC interpretation, coagulation studies, 20%
anemia classification, WBC disorders, bone
marrow morphology
Clinical Chemistry 51-100 Electrolytes, renal function tests, liver 20%
function tests, enzymes, therapeutic drug
monitoring, acid-base balance
Microbiology 101-150 Bacterial identification, antibiotic 20%
susceptibility, virology, mycology,
parasitology, specimen collection and
handling
Immunohematology (Blood 151-200 Blood typing, antibody screening and 20%
Bank) identification, crossmatching, component
therapy, transfusion reactions
Laboratory Operations and 201-250 Quality control, laboratory mathematics, 20%
Safety infection control, chemical hygiene,
regulatory compliance, phlebotomy
Page 1
,Q1. A patient's RBCs type as A, Rh-negative, and the serum contains anti-D. The antibody screen is
negative. A crossmatch with 2 units of A-negative RBCs yields incompatible reactions at immediate
spin (IS) but negative at 37°C and AHG. Which phenomenon most likely explains these results?
A. Cold autoantibody with anti-I specificity
B. Passively acquired anti-D from Rh immune globulin
C. Antibody to a low-incidence antigen present on donor cells
D. Rouleaux formation due to elevated serum proteins
Correct Answer: D. Rouleaux formation due to elevated serum proteins
Rationale: Rouleaux causes weak, reversible agglutination that is most apparent at IS and resolves with
warm saline replacement or 37°C incubation. It is non-immune and not due to antibody. The negative
antibody screen and negative 37°C/AHG phases rule out immune-mediated incompatibility.
Why Wrong:
A - Cold autoantibodies typically react strongly at 4°C, not exclusively at IS, and would often cause
positive antibody screen.
B - Passively acquired anti-D would cause a positive antibody screen and usually react at AHG, not
confined to IS.
C - Antibodies to low-incidence antigens often react at AHG or 37°C, not exclusively at IS.
Reference: Harmening, D. (2014). Modern Blood Banking & Transfusion Practices, 6th Ed., Ch. 12.
Q2. Which laboratory result is most consistent with chronic myeloid leukemia (CML) in the chronic
phase?
A. Leukocyte alkaline phosphatase (LAP) score markedly increased with left shift
B. Cytogenetic analysis showing t(9;22) with BCR-ABL1 fusion in 90% of metaphases
C. Peripheral smear demonstrating >30% blasts with Auer rods and pseudo-Pelger-Huët cells
D. Bone marrow biopsy revealing dysplastic changes in all three lineages
Correct Answer: B. Cytogenetic analysis showing t(9;22) with BCR-ABL1 fusion in 90% of
metaphases
Rationale: The Philadelphia chromosome (t(9;22)) is diagnostic of CML and present in >90% of chronic
phase cases. LAP is decreased in CML, not increased. >30% blasts with Auer rods suggests AML, not
CML chronic phase. Dysplastic changes are characteristic of MDS.
Why Wrong:
A - LAP score is decreased in CML; increased LAP suggests a leukemoid reaction.
C - Blasts 20% in blood or marrow defines acute leukemia; Auer rods indicate AML.
D - Dysplasia in multiple lineages is diagnostic of myelodysplastic syndromes.
Reference: Bain, B. (2015). Leukaemia Diagnosis, 4th Ed., Ch. 5.
Page 2
,Q3. In a reaction catalyzed by lactate dehydrogenase (LDH), the rate of NADH oxidation is
measured spectrophotometrically at 340 nm. If the sample has a very high LDH activity, which of
the following is the most appropriate action to ensure accurate measurement?
A. Increase the incubation temperature to 37°C
B. Dilute the sample with saline and re-assay
C. Pre-incubate the sample with NAD+ to saturate coenzyme binding
D. Use a higher substrate concentration to overcome substrate inhibition
Correct Answer: B. Dilute the sample with saline and re-assay
Rationale: If LDH activity is very high, the reaction may consume all available NADH quickly, leading to
a non-linear rate and underestimated activity. Diluting the sample brings the activity into the linear range
of the assay, ensuring accurate measurement.
Why Wrong:
A - Increasing temperature increases reaction rate but does not correct for substrate depletion or
linearity.
C - Pre-incubation with NAD+ would not help; LDH uses NADH/NAD+ pair, and saturating is not
an issue.
D - Substrate inhibition is not typical for LDH; increasing substrate may cause inhibition but does
not address high sample activity.
Reference: Burtis, C.A. et al. (2012). Tietz Textbook of Clinical Chemistry and Molecular Diagnostics,
5th Ed., Ch. 8.
Q4. A Gram-negative rod isolated from a blood culture is resistant to amikacin but susceptible to
gentamicin. Which mechanism of resistance is most likely present?
A. Efflux pump that removes amikacin but not gentamicin
B. Aminoglycoside acetyltransferase (AAC) with specificity for amikacin
C. Reduced porin expression affecting amikacin uptake more than gentamicin
D. Ribosomal methylation that alters binding of amikacin only
Correct Answer: B. Aminoglycoside acetyltransferase (AAC) with specificity for amikacin
Rationale: Aminoglycoside modifying enzymes (AMEs) such as AAC(6')-I specifically acetylate amikacin
and other aminoglycosides, while gentamicin is less affected by this enzyme. This differential resistance
pattern is classic for AAC(6')-I.
Why Wrong:
A - Efflux pumps commonly affect multiple aminoglycosides, not selectively amikacin; gentamicin
would also be affected.
C - Porin loss reduces uptake of all aminoglycosides to some extent; differential effect is unlikely.
D - Ribosomal methylation (e.g., armA) confers high-level resistance to all aminoglycosides, not just
amikacin.
Reference: CLSI M100-S25 (2015). Performance Standards for Antimicrobial Susceptibility Testing.
Page 3
, Q5. Which interpretation is correct for an ELISA assay where the patient's optical density (OD)
exceeds the cutoff established by the mean of negative controls plus 3 standard deviations?
A. The result is positive for the antibody of interest, with 99% confidence given the chosen cutoff
B. The result is indeterminate and requires confirmatory testing because the cutoff is too stringent
C. The result is considered reactive but may represent a false positive if the sample has hemolysis
D. The result indicates a high titer of antibody, as OD correlates directly with concentration
Correct Answer: A. The result is positive for the antibody of interest, with 99% confidence given the
chosen cutoff
Rationale: Using mean + 3 SD is the standard cutoff for ELISA to achieve a 99.7% specificity (assuming
normal distribution). A patient OD above this cutoff is considered positive with high probability. OD does
not directly reflect titer; titration requires serial dilutions.
Why Wrong:
B - Indeterminate zone is usually between cutoff and a lower threshold; mean+3SD is a common
positive cutoff, not too stringent.
C - Hemolysis may cause non-specific binding but does not systematically cause false positives; the
cutoff is designed to avoid such.
D - OD is not linear with antibody concentration across all ranges; titer is determined by endpoint
dilution.
Reference: Abbas, A.K. et al. (2018). Cellular and Molecular Immunology, 9th Ed., Ch. 6.
Q6. A urine specimen appears dark brown. Dipstick is negative for blood and bilirubin. Which
finding on microscopic examination would best explain the color?
A. Numerous red blood cells with dysmorphic morphology
B. Crystals of uric acid in a concentrated sample
C. Pigmented casts and presence of myoglobin casts
D. Squamous epithelial cells with hemosiderin granules
Correct Answer: C. Pigmented casts and presence of myoglobin casts
Rationale: Dark brown urine without blood or bilirubin suggests myoglobinuria or hemoglobinuria.
Myoglobinuria often results from muscle injury; myoglobin casts may be seen. Hemoglobinuria would
show free hemoglobin but the dipstick may be positive for blood. Myoglobin does not react on dipstick as
strongly, and presence of pigmented casts supports myoglobin.
Why Wrong:
A - RBCs would cause a positive dipstick for blood; the specimen would be red, not brown.
B - Uric acid crystals do not produce a dark brown color; they are yellow-brown but urine would not
be dark brown.
D - Hemosiderin granules indicate old RBC breakdown but dipstick would be positive for blood;
color would be reddish.
Reference: Strasinger, S.K. & Di Lorenzo, M.S. (2014). Urinalysis and Body Fluids, 6th Ed., Ch. 7.
Page 4
